159 related articles for article (PubMed ID: 26152557)
21. A transgenic mouse model for the ductal carcinoma in situ (DCIS) of the mammary gland.
Schulze-Garg C; Löhler J; Gocht A; Deppert W
Oncogene; 2000 Feb; 19(8):1028-37. PubMed ID: 10713686
[TBL] [Abstract][Full Text] [Related]
22. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
23. BI-RADS-MRI terminology and evaluation of intraductal carcinoma and ductal carcinoma in situ.
Tozaki M
Breast Cancer; 2013 Jan; 20(1):13-20. PubMed ID: 22109641
[TBL] [Abstract][Full Text] [Related]
24. Magnetic Resonance Angiography Shows Increased Arterial Blood Supply Associated with Murine Mammary Cancer.
Mustafi D; Leinroth A; Fan X; Markiewicz E; Zamora M; Mueller J; Conzen SD; Karczmar GS
Int J Biomed Imaging; 2019; 2019():5987425. PubMed ID: 30792738
[TBL] [Abstract][Full Text] [Related]
25. Defining an optimal role for breast magnetic resonance imaging when evaluating patients otherwise eligible for accelerated partial breast irradiation.
Horst KC; Fero KE; Ikeda DM; Daniel BL; Dirbas FM
Radiother Oncol; 2013 Aug; 108(2):220-5. PubMed ID: 23597699
[TBL] [Abstract][Full Text] [Related]
26. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement.
Neubauer H; Li M; Kuehne-Heid R; Schneider A; Kaiser WA
Br J Radiol; 2003 Jan; 76(901):3-12. PubMed ID: 12595319
[TBL] [Abstract][Full Text] [Related]
27. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of mammary lesions represent molecular differences.
Namba R; Maglione JE; Davis RR; Baron CA; Liu S; Carmack CE; Young LJ; Borowsky AD; Cardiff RD; Gregg JP
BMC Cancer; 2006 Dec; 6():275. PubMed ID: 17147824
[TBL] [Abstract][Full Text] [Related]
29. Preoperative breast magnetic resonance imaging in early breast cancer: implications for partial breast irradiation.
Tendulkar RD; Chellman-Jeffers M; Rybicki LA; Rim A; Kotwal A; Macklis R; Obi BB
Cancer; 2009 Apr; 115(8):1621-30. PubMed ID: 19224552
[TBL] [Abstract][Full Text] [Related]
30. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
31. Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression.
Kupferman ME; Fini ME; Muller WJ; Weber R; Cheng Y; Muschel RJ
Am J Pathol; 2000 Dec; 157(6):1777-83. PubMed ID: 11106549
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging of trabecular and cortical bone in mice: comparison of high resolution in vivo and ex vivo MR images with corresponding histology.
Weber MH; Sharp JC; Latta P; Sramek M; Hassard HT; Orr FW
Eur J Radiol; 2005 Jan; 53(1):96-102. PubMed ID: 15607859
[TBL] [Abstract][Full Text] [Related]
33. Regulatory T Cells Control the Switch From
Martinez LM; Robila V; Clark NM; Du W; Idowu MO; Rutkowski MR; Bos PD
Front Immunol; 2019; 10():1942. PubMed ID: 31555258
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
Fleming NI; Trivett MK; George J; Slavin JL; Murray WK; Moseley JM; Anderson RL; Thomas DM
Cancer Res; 2009 Sep; 69(18):7473-9. PubMed ID: 19723659
[TBL] [Abstract][Full Text] [Related]
35. Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL; Chung MA
Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
[TBL] [Abstract][Full Text] [Related]
36. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
37. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE
Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188
[TBL] [Abstract][Full Text] [Related]
38. Ductal carcinoma in situ in rat mammary gland.
Crist KA; Chaudhuri B; Shivaram S; Chaudhuri PK
J Surg Res; 1992 Mar; 52(3):205-8. PubMed ID: 1311399
[TBL] [Abstract][Full Text] [Related]
39. The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
Shibata MA; Jorcyk CL; Liu ML; Yoshidome K; Gold LG; Green JE
Toxicol Pathol; 1998; 26(1):177-82. PubMed ID: 9502400
[No Abstract] [Full Text] [Related]
40. [MRI outstands mammogram in sensitivity of breast ductal carcinoma in situ:an analysis of 122 cases].
Yu QX; Chen XS; Wu JY; Han BS; He JR; Zhu L; Chen WG; Li YF; Tan L; Chai WM; Wang DB; Fei XC; Yuan F; Jin XL; Shen KW; Li HW
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):26-9. PubMed ID: 23578423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
